Cosentyx (secukinumab) is a fully human IgG1/κ monoclonal antibody that selectively binds to and neutralizes the proinflammatory cytokine interleukin-17A (IL-17A). ¹ Cosentyx works by targeting IL-17A and inhibiting its interaction with...